Chancellor Rachel Reeves Intends Specific Action on Household Expenses in Forthcoming Financial Plan
Chancellor Reeves has announced she is preparing "specific action to tackle cost of living pressures" in the forthcoming financial statement.
In comments to the BBC, she stated that curbing inflation is a collective duty of both the administration and the Bank of England.
The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven industrialized countries this year and next.
Possible Utility Bill Measures
Reports indicate the administration could take action to bring down utility costs, for instance by cutting the current 5% level of value-added tax applied on energy.
A further option is to lower some of the government charges presently added to bills.
Fiscal Limitations and Expert Expectations
The administration will receive the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much room there is for these actions.
The view from the majority of experts is that the Chancellor will have to introduce tax rises or expenditure reductions in order to adhere to her declared debt limits.
Previously on Thursday, analysis showed there was a £22 billion shortfall for the Treasury chief to address, which is at the more modest range of forecasts.
"There's a collective responsibility between the central bank and the government to further reduce some of the sources of inflation," the Chancellor informed reporters in the US capital, at the annual meetings of the IMF and World Bank.
Tax Commitments and International Concerns
While a great deal of the focus has been on likely tax increases, the chancellor said the most recent data from the OBR had not altered her vow to election pledges not to raise tax levels on income tax, sales tax or social security contributions.
She blamed an "uncertain world" with rising geopolitical and commercial issues for the Budget revenue measures, probably to be targeted on those "wealthiest."
International Trade Disputes
Commenting on apprehensions about the UK's economic relations with China she said: "Our national security invariably take priority."
Last week's declaration by Chinese authorities to tighten trade restrictions on rare earths and other materials that are essential for high-technology manufacturing led American leader the US President to suggest an additional 100% tariff on goods from the Asian country, increasing the possibility of an full-scale trade war between the two economic giants.
The American finance chief described China's move "commercial pressure" and "a international production control attempt."
Asked about accepting the US offer to join its conflict with China, the Chancellor said she was "very concerned" by China's actions and called on the Beijing authorities "not to put up barriers and restrict access."
She said the decision was "harmful for the world economy and generates further headwinds."
"I believe there are areas where we should challenge China, but there are also significant opportunities to export to China's economy, including banking sector and other areas of the economy. We've got to achieve that balance correct."
The Treasury chief also confirmed she was cooperating with international partners "on our own critical minerals plan, so that we are less reliant."
Health Service Drug Pricing and Funding
Reeves also recognized that the price the National Health Service spends on drugs could go up as a result of ongoing discussions with the US government and its drugs companies, in exchange for lower tariffs and capital.
Some of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or scrapping operations in the United Kingdom, with several attributing the insufficient payments they are receiving.
Recently, the government science advisor said the cost the NHS pays for drugs would need to rise to stop businesses and pharmaceutical investment leaving the UK.
The Chancellor told media: "We have seen as a result of the pricing regime, that clinical trials, innovative medicines have not been provided in the United Kingdom in the way that they are in other European countries."
"Our aim is to guarantee that people receiving treatment from the NHS are able to access the best essential treatments in the globe. And so we are looking at all of that, and... seeking to secure more capital into Britain."